Merck & Co., Inc. (MRK)
Loading chart
Key facts
- Open
- Previous close
- Day range
- 52-week range
- Volume
- Short % of shares
- Days to cover
- Market cap
- 361.73B
- Exchange
- XNYS
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
- Industry
- PHARMACEUTICAL PREPARATIONS
- Employees
- 75,000
- Listed
- 1949-04-20
- Website
- www.merck.com